4 Stocks With Strong Technical Momentum

A number of stocks are looking strong technically this week with the market's upside reversal. Here are four to watch.

Akorn, Inc. AKRX had a strong reversal session on Tuesday, up $1.05 or 3.28%, to $33.04. After surging in the second week of April on news of being in talks to be acquired by Fresenius Medical Care AG & Co. (ADR) FMS, the stock flagged in recent sessions, and looked to be continuing lower on Tuesday, reaching $31.29 intraday before bouncing. The stock closed with volume of 5.3 million shares, the highest in about five sessions. Resistance is at $33.60, the high from April 10. Through there, the next target is $35, followed by $39-$39.50.

Akari Therapeutics PLC (ADR) AKTX also had a big reversal session on Tuesday, rallying $1.66, or 12.4%, to $14.97 on 714,600 shares. The move, which came on no news, reversed a week-long pullback that saw the stock drop from a high of $22.20 on April 10 to a low of $12.30 on April 17. That pullback followed a huge 10-day surge, in which the stock tripled from under 7 on news the FDA granted one of the company's drugs a "fast track" designation. Resistance is at $16, and, if the stock gets through that, watch for a target in the $18.50-$19 zone.

MiMedx Group Inc MDXG has been up four sessions in a row, climbing more than 15%. Last Thursday the biopharmaceutical company announced that first-quarter revenue topped the high end of guidance. The top of the nearly 2-month rising channel points to $11.50-.75, a level last reached in September 2015. That's our initial target, followed by $12.75. Short interest is a whopping 32.7x average volume, which means that a price advance could be greatly accelerated by short covering.

Stratasys, Ltd. SSYS had a significant, high-volume breakaway gap on Tuesday, closing at the upper end of the range. The stock gained $2.47, or 11.6%, to $23.77, on 3 million shares traded, or more than four times its average volume. A Piper Jaffray Companies PJC analyst upgraded his view on the 3D printing specialist from neutral to overweight and increased his price target to $28. Technically, if the stock can get through the $25 zone, then the target is $28, last reached a year ago (April 2016), and then possibly $30.

See Harry's video chart analysis on these stocks.

No holdings.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechHealth CareTechnicalsOpinionMarketsTrading Ideascontributor
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...